Scientific Reports (Jan 2022)

Direct evidence of proximal tubular proliferation in early diabetic nephropathy

  • Noriko Uehara-Watanabe,
  • Natsuko Okuno-Ozeki,
  • Atsushi Minamida,
  • Itaru Nakamura,
  • Tomohiro Nakata,
  • Kunihiro Nakai,
  • Aya Yagi-Tomita,
  • Tomoharu Ida,
  • Kisho Ikeda,
  • Takashi Kitani,
  • Noriyuki Yamashita,
  • Michitsugu Kamezaki,
  • Yuhei Kirita,
  • Satoaki Matoba,
  • Keiichi Tamagaki,
  • Tetsuro Kusaba

DOI
https://doi.org/10.1038/s41598-022-04880-1
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Kidney hypertrophy is a common clinical feature in patients with diabetes and is associated with poor renal outcomes. Initial cell proliferation followed by cellular hypertrophy are considered the responsible mechanisms for diabetic kidney hypertrophy. However, whether similar responses against hyperglycemia continue in the chronic phase in diabetes is unclear. We performed lineage tracing analysis of proximal tubular epithelia using novel type 2 diabetic mice with a tamoxifen-inducible proximal tubule-specific fluorescent reporter. Clonal analysis of proximal tubular epithelia demonstrated that the labeled epithelia proliferated in type 2 diabetic mice. Based on the histological analysis and protein/DNA ratio of sorted labeled tubular epithelia, there was no evidence of cellular hypertrophy in type 2 diabetic mice. Lineage tracing and histological analyses of streptozocin-induced type 1 diabetes also revealed that cellular proliferation occurs in the chronic phase of type 1 diabetes induction. According to our study, epithelial proliferation accompanied by SGLT2 upregulation, rather than cellular hypertrophy, predominantly occurs in the hypertrophic kidney in both type 1 and type 2 diabetes. An increased number of SGLT2+ tubular epithelia may be an adaptive response against hyperglycemia, and linked to the hyper-reabsorption of sodium and glucose observed in type 2 diabetes patients.